Treating Caregivers Who Smoke at AFCH (NCT06051474) | Clinical Trial Compass
CompletedPhase 4
Treating Caregivers Who Smoke at AFCH
United States23 participantsStarted 2024-03-05
Plain-language summary
The purpose of this research study is to 1) see if a smoking cessation program is something that caregivers will use while their child is hospitalized, 2) see if caregivers think this program is something we should institute across the hospital, and 3) see if this program can help caregivers reduce their smoking.
Participants will:
* Complete a survey regarding smoking behavior and thoughts about quitting;
* Undergo a 20-minute counseling session; and,
* Use nicotine patches and mini-lozenges for 2 weeks
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Hospitalized child will have a 'yes' response to the screening question, "Does anyone in your household smoke"
* Hospitalized child is expected to be admitted for \>24 hours
* Caregiver is at least 18 years of age
* Participant self-identifies as the primary caregiver of the hospitalized child during the hospitalization
* Participant smokes ≥5 cigarettes per day
* Participant is willing and able to use NRT
* Participant is not currently pregnant, trying to get pregnant, or breastfeeding and willing to use acceptable birth control for duration of medication use
* Participant is willing to comply with all study procedures and be available for the duration of the study
Exclusion Criteria:
* Contraindication to NRT use (pregnancy, myocardial infarction in past 2 weeks)
* Previous reaction to the nicotine patch or mini-lozenge that prevented them from continuing to use it
* Current use of smoking cessation medications (any NRT, bupropion, varenicline)
* Caregiver's child is being cared for by study physician (Dr. Brian Williams)
* Need for an interpreter
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Enrollment in Study
Timeframe: Study recruitment, approximately 6 months